INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 206S206 trades$1.10M
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$22.46M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,770 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
DN
Donnelly NoelChief Financial Officer
PEPGPepGen Inc.
Disposition to issuer
D—
203.3K sh
Nov 4, 2025Dec 18, 2025
Page 1594 of 1820
← PrevNext →
traded Nov 4, 2025
+44d
SEC Form 4

Evidence

24
MG
McArthur James GDirector, President and CEO
PEPGPepGen Inc.
Grant or award
A—
40.8K sh
Nov 4, 2025Dec 18, 2025
traded Nov 4, 2025
+44dSEC Form 4

Evidence

24
MG
McArthur James GDirector, President and CEO
PEPGPepGen Inc.
Disposition to issuer
D—
40.8K sh
Nov 4, 2025Dec 18, 2025
traded Nov 4, 2025
+44dSEC Form 4

Evidence

23
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$74K
10.9K sh
Dec 11, 2025Dec 18, 2025
traded Dec 11, 2025
+7dSEC Form 4

Evidence

23
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$52K
7,603 sh
Dec 12, 2025Dec 18, 2025
traded Dec 12, 2025
+6dSEC Form 4

Evidence

23
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$69K
10.6K sh
Dec 15, 2025Dec 18, 2025
traded Dec 15, 2025
+3dSEC Form 4

Evidence

23
MA
Muralidharan AnuradhaDirector, Chief Operating Officer
EXFYExpensify, Inc.
Grant or award
A$31K
18.6K sh
Dec 15, 2025Dec 18, 2025
traded Dec 15, 2025
+3dSEC Form 4

Evidence

22
MF
Mills Jason FahrDirector
EXFYExpensify, Inc.
Grant or award
A$71K
43.1K sh
Dec 15, 2025Dec 18, 2025
traded Dec 15, 2025
+3dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$14K
97 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$18K
127 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
MR
Markus RichardChief Medical Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
5,052 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$31K
215 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$48K
334 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$18K
131 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$3,920
26 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$49K
331 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

22
TC
Tang Carolyn C.General Counsel
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$168K
7,658 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
3,841 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,689 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
BR
Bischoff Gerald RVP and Corporate Controller
TXNMTXNM ENERGY INC
Option exercise
M—
638 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

21
JM
Jacobson MoniqueSVP, Corporate Services
TXNMTXNM ENERGY INC
Tax withholding
F$17K
298 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

21
HF
Hamadi FaisalVice President
KMTKENNAMETAL INC
Option exercise
M—
2,133 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$552K
2,872 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
JA
Jain AshishChief Technology Officer
OSPNOneSpan Inc.
Tax withholding
F$43K
3,384 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$569K
2,600 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
AM
Aisquith Anthony MDirector, Chief Executive Officer
ONEWOneWater Marine Inc.
Grant or award
A—
95.9K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
JA
Jain AshishChief Technology Officer
OSPNOneSpan Inc.
Option exercise
M—
9,456 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

21
MJ
Morrissey Michael JamesEVP, Head of Tech. Operations
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$420K
4,323 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

21
WF
Whalen James F.Director
CBNKCapital Bancorp Inc
Option exercise
M$17K
1,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

20
WC
Whitfield Dianne C.Chief Human Resources Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$592K
7,397 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

20
NK
Newton William KeithDirector, Chief Executive Officer
CONConcentra Group Holdings Parent, Inc.
Gift
G—
89.1K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

20
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Option exercise
M$97K
100.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

19
PN
Patel Priyen NChief Strategy & Legal Officer
LTCHLatch, Inc.
Tax withholding
F$3,338
23.8K sh
Dec 15, 2025Dec 18, 2025
traded Dec 15, 2025
+3dSEC Form 4

Evidence

19
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Tax withholding
F$777K
10.5K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

19
SR
Schaffer RyanDirector, Chief Financial Officer
EXFYExpensify, Inc.
Grant or award
A$22K
13.6K sh
Dec 15, 2025Dec 18, 2025
traded Dec 15, 2025
+3dSEC Form 4

Evidence

18
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Open-market sale · 10b5-1 plan
SELL$107K
9,102 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

18
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
2,376 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

18
MR
Markus RichardChief Medical Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$100K
4,494 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

18
AA
Azoy AlexanderChief Accounting Officer
RCUSArcus Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$97K
4,343 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

18
MJ
Morrissey Michael JamesEVP, Head of Tech. Operations
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$81K
833 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence